Frontiers in Genetics is a premier academic journal dedicated to advancing the field of genetics through high-quality, peer-reviewed research. Published by FRONTIERS MEDIA SA in Switzerland since 2010, this Open Access journal provides a platform for researchers and practitioners to disseminate innovative findings across various subfields, including clinical genetics and molecular medicine. With a notable emphasis on interdisciplinary approaches, the journal holds a strong position in the academic landscape, achieving Q2 rankings in key categories such as Genetics and Molecular Medicine in 2023. Not only does Frontiers in Genetics contribute to the scholarly dialogue by publishing impactful studies, but it also promotes accessibility to vital research, ensuring that knowledge is available to a global audience. This journal is a vital resource for researchers, professionals, and students looking to stay at the forefront of genetic discoveries and their applications, reflective of its engagement with contemporary challenges in genetics and healthcare.

GENETICS AND MOLECULAR RESEARCH is a distinguished academic journal published by FUNPEC-EDITORA, focusing on the rapidly evolving fields of genetics and molecular biology. Since its inception in 2002, the journal has provided a platform for high-quality research and advancements that contribute to our understanding of genetic mechanisms and molecular interactions. With an impressive convergence period extending through 2024, this open-access journal presents vital insights while maintaining accessibility for researchers, professionals, and students alike. Though currently positioned in the Q4 quartile in Genetics, Medicine (Miscellaneous), and Molecular Biology as per the latest 2023 rankings, its persistent publication efforts aim to elevate its influence within the academic community. Researchers are invited to explore groundbreaking studies that may inform future developments in these critical scientific domains.

BMC Medical Genomics is a prominent peer-reviewed open-access journal published by BMC, specializing in the integration of genomics within the medical field. Since its inception in 2008, this journal has positioned itself at the forefront of genomic research, contributing to significant advancements in understanding the genetic underpinnings of diseases. With an impressive impact factor reflective of its rigorous scholarship, BMC Medical Genomics holds a prestigious Q2 ranking in the field of Genetics and a Q3 ranking in Clinical Genetics, showcasing its relevance and influence in shaping contemporary research paradigms. The journal is recognized in various databases, including Scopus, where it ranks 58th in Clinical Genetics, emphasizing its importance within the medical community. By facilitating open access to its comprehensive articles, BMC Medical Genomics aims to foster collaboration among researchers, healthcare professionals, and students, thereby enhancing the collective understanding of genomics in medicine. Its commitment to delivering high-quality research makes it an essential resource for those immersed in this dynamic and rapidly evolving field.

The Egyptian Journal of Medical Human Genetics is a distinguished Open Access journal published by SPRINGER NATURE, dedicated to advancing the field of medical human genetics. With an ISSN of 1110-8630 and an E-ISSN of 2090-2441, this journal serves as a vital platform for researchers, professionals, and students who are committed to the exploration of genetic implications on human health. Since its inception in 2010, it has become a growing repository of knowledge, significantly contributing to the discourse in clinical genetics, despite currently being ranked in the Q4 quartile of its category in 2023. The journal embraces an open access model, ensuring widespread visibility and accessibility of published research, thereby fostering collaboration and innovation in the field. The journal is not only aimed at disseminating findings but also at encouraging the dialogue around genetic research developments, making it an essential resource for anyone interested in the nuances of genetics and its impact on medicine.

Genes & Genomics is a prominent academic journal dedicated to the fields of biochemistry, genetics, and molecular biology, published by Springer from South Korea. With an evolving focus on innovative genetic research and its implications, this journal serves as a crucial platform for disseminating knowledge within the scientific community. The journal has been indexed in Scopus and boasts a Q3 quartile ranking in 2023 for its contributions to these disciplines, highlighting its relevance and growing impact. In addition to traditional subscription options, Genes & Genomics supports Open Access, offering broader accessibility for researchers and enthusiasts eager to explore the latest advancements in genetic studies. Since its inception in 2008, the journal has committed to publishing high-quality research that drives forward our understanding of genetics and its applications, making it an essential resource for researchers, professionals, and students alike who are passionate about the complexities and breakthroughs in genomic sciences.

The Journal of Genetics and Genomics, published by SCIENCE PRESS in China, stands as a significant contributor to the fields of Genetics and Molecular Biology. With an ISSN of 1673-8527 and E-ISSN 1873-5533, this esteemed journal has achieved a remarkable reputation, holding a prestigious Q1 ranking in both Genetics and Molecular Biology as of 2023. This journal not only showcases pioneering research but also fosters vital discussions on contemporary challenges and innovations within genomic sciences. As part of its commitment to facilitating scientific advancement, the journal encompasses a range of research articles, reviews, and short communications, all aiming to illuminate the complexities of genetic structures and functions from 2007 to 2024. Researchers, professionals, and students alike are encouraged to engage with its content, which ranks favorably in Scopus—placing it within the top tier of its categories. Join the community of academic excellence and explore the latest findings that shape our understanding of genomics.

Genome Medicine is a prestigious, peer-reviewed journal published by BMC, focusing on the rapidly evolving fields of genetics, molecular biology, and molecular medicine. Established in 2009 and boasting an open-access format, it has become a leading platform for disseminating high-quality research findings that advance our understanding of genetic diseases and therapeutic innovations. With an impressive Q1 ranking across multiple relevant categories—in particular, genetics (clinical), molecular biology, and molecular medicine—this journal is recognized for its substantial impact in the academic community, as evidenced by its exceptional placement in Scopus rankings. By providing unrestricted access to groundbreaking studies, Genome Medicine fosters collaboration and knowledge sharing among researchers, clinicians, and educators, thus playing a vital role in the transition from fundamental genetic research to clinical applications. Researchers are encouraged to contribute their findings and insights, further solidifying the journal’s position as a pivotal resource for those dedicated to advancing genomic medicine.

Application of Clinical Genetics is a premier open-access journal published by Dove Medical Press Ltd., dedicated to advancing the field of clinical genetics since its inception in 2008. Based in New Zealand, this journal has established itself as a significant resource for researchers, clinicians, and students alike, contributing to the body of knowledge in both genetic medicine and clinical applications. With an impact factor reflecting its contributions to the field, the journal holds positions in the Q2 and Q3 quartiles of the 2023 Genetics categories, showcasing its relevance and scientific merit. Furthermore, it ranks #43 out of 99 in Clinical Genetics and #153 out of 347 in Biochemistry, Genetics, and Molecular Biology, indicating robust performance amongst its peers. The journal’s broad scope, encompassing various aspects of clinical genetics, ensures that it remains at the forefront of critical discussions, innovative research, and applications essential for the progression of personalized medicine. Researchers and professionals are encouraged to explore its openly accessible content that fosters collaboration and the sharing of knowledge in this dynamic and rapidly evolving field.

CYTOGENETIC AND GENOME RESEARCH is a pivotal journal dedicated to the exploration of cytogenetics, genomics, and their applications within clinical genetics and molecular biology. Published by KARGER in Switzerland, this journal aims to foster comprehensive discussions and disseminate impactful research from diverse fields related to genetics. It operates under an open access model, ensuring that researchers, professionals, and students can easily access and contribute to the latest findings. With coverage spanning from 1962 to 2024, CYTOGENETIC AND GENOME RESEARCH continues to serve as a vital resource, despite its current categorization in the Q4 quartile across Genetics and Molecular Biology. It provides an avenue for advancing the understanding of genomic mechanisms and their implications for human health. The journal encourages submissions that delve into cutting-edge methodologies, data interpretation, and theoretical frameworks, thereby playing a crucial role in the advancement of genetic research and its clinical applications.

The Journal of Gene Medicine, published by Wiley, stands as a pivotal resource in the field of gene therapy and molecular medicine, with a rich history of dissemination of impactful research since its inception in 1998. With an ISSN of 1099-498X and an E-ISSN of 1521-2254, this esteemed journal plays a crucial role in advancing our understanding of genetics and drug discovery, reflected in its impressive 2023 Scopus rankings where it holds a Q2 classification in Drug Discovery and Q3 in several genetics-related categories. The journal aims to facilitate the exchange of high-quality research findings that bridge the gap between laboratory and clinical applications, making it an essential platform for researchers, academics, and healthcare professionals committed to the forefront of genetic innovation. Although it does not currently offer open access options, its reputation for rigorous peer review ensures that all published work meets the highest academic standards, providing a reliable reference for scientific inquiry in the United States and beyond. As the field rapidly evolves, the Journal of Gene Medicine remains at the helm, guiding future discoveries with its influential publications and comprehensive insights.